Form 8-K - Current report:
SEC Accession No. 0001493152-24-048170
Filing Date
2024-11-29
Accepted
2024-11-29 16:15:38
Documents
18
Period of Report
2024-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55803
2 ex4-1.htm EX-4.1 201404
3 ex10-1.htm EX-10.1 196232
4 ex10-2.htm EX-10.2 109892
5 ex10-3.htm EX-10.3 76947
6 ex10-4.htm EX-10.4 178532
  Complete submission text file 0001493152-24-048170.txt   1160901

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE lucd-20241122.xsd EX-101.SCH 3039
8 XBRL LABEL FILE lucd-20241122_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE lucd-20241122_pre.xml EX-101.PRE 24181
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3811
Mailing Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017
Business Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 212 949 4319
Lucid Diagnostics Inc. (Filer) CIK: 0001799011 (see all company filings)

EIN.: 825488042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40901 | Film No.: 241516541
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)